SEC Form 4 · accession 0002013623-26-000012
EyePoint, Inc. · EYPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramiro Ribeiro
Officer — Chief Medical Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 2, 2026 · 4:03 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001314102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | M | 2,437 | $8.26 | A | 2,437 | D | |
| Common Stock | Jun 30, 2026 | M | 2,438 | $8.26 | A | 4,875 | D | |
| Common Stock | Jun 30, 2026 | S | 2,437 | $15.00 | D | 2,438 | D | |
| Common StockF1 | Jun 30, 2026 | S | 2,438 | $15.0172 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $8.26 | Jun 30, 2026 | M | 2,437 | D | — | Jan 3, 2035 | Common Stock | 2,437 | 78,001 | D |
| Stock Option (Right to Buy)F2 | $8.26 | Jun 30, 2026 | M | 2,438 | D | — | Jan 3, 2035 | Common Stock | 2,438 | 75,563 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.06. The reporting person undertakes to provide EyePoint Inc., any security holder of EyePoint Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option to purchase will vest and become exercisable as follows: 25% at January 3, 2026 and the remainder ratably, on a monthly basis, over the remaining three years.